Insider · CIK 0001239956
Wendell Wierenga
director
Files at CRNX (Crinetics Pharmaceuticals, Inc.), DRMA (Dermata Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -116,146 | $85.00 | $9.9M | 5,925 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -5,925 | $85.00 | $504k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $61.76 | $772k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $61.77 | $772k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.77 | $1.1M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $66.71 | $1.2M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.68 | $1.1M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $40.29 | $504k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,350 | $52.67 | $545k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,730 | $49.13 | $478k | 0 | 41 d ago |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Jan 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.